Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ImmunoPrecise Antibodies Ltd. - Common Stock
(NQ:
IPA
)
1.589
+0.279 (+21.27%)
Streaming Delayed Price
Updated: 1:04 PM EDT, Jul 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ImmunoPrecise Antibodies Ltd. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Stocks That Hit 52-Week Lows On Tuesday
February 15, 2022
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...
Via
Benzinga
ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron
January 31, 2022
Immunoprecise Antibodies Ltd (NASDAQ: IPA) has released preclinical data for the PolyTope TATX-03 COVID-19 antibody cocktail.
Via
Benzinga
Analyzing ImmunoPrecise Antibodies's Unusual Options Activity
August 09, 2021
On Monday, shares of ImmunoPrecise Antibodies (NASDAQ:IPA) ...
Via
Benzinga
Unusual Options Activity Insight: ImmunoPrecise Antibodies
August 04, 2021
Shares of ImmunoPrecise Antibodies (NASDAQ:IPA) saw some un...
Via
Benzinga
Immunotherapeutic PolyTope® from ImmunoPrecise (IPA) Potently Neutralizes the SARS-CoV-2 Omicron Variant – Moves Towards FDA/IND-Submission
January 31, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Relocates European Subsidiary to LEED Certified Campus to Continue to Advance its Antibody Research Operations and Environmental Sustainability
January 18, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies Announces Grant of Stock Options
January 17, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies Announces Grant of Stock Options
January 11, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies Announces Grant of Stock Options
January 03, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope® TATX-03 Antibody Cocktail Manufacturing Collaboration
December 20, 2021
From
IMMUNOPRECISE ANTIBODIES LTD.
Via
Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022
December 13, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022
December 07, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development Program
November 30, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
56 Biggest Movers From Friday
November 29, 2021
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...
Via
Benzinga
ImmunoPrecise to Present at the Benchmark Company’s Discovery One-on-One Virtual Video Investor Conference on Thursday December 2, 2021
November 24, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...
Via
Benzinga
IPA Announces Resignation of Director
November 09, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
October 25, 2021
Upgrades According to Wedbush, the prior rating for Regions Financial Corp (NYSE:
Via
Benzinga
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
October 13, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
October 07, 2021
From
ImmunoPrecise Antibodies Ltd
Via
Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2022
September 09, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Earnings Scheduled For September 9, 2021
September 09, 2021
Companies Reporting Before The Bell • Li-Cycle Holdings (NYSE:LICY) is likely to report earnings for its third quarter. • Trinity Biotech (NASDAQ:TRIB) is...
Via
Benzinga
ImmunoPrecise’s Dutch Subsidiary Receives French Research Tax Credit (CIR) Accreditation
September 08, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021 (Virtual Conference)
September 07, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Announces Participation at the H.C. Wainwright 23nd Annual Global Investment Conference on September 13-15, 2021 (Virtual Conference)
September 07, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2022
September 03, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Welcomes Vice President of Client Relations and Vice President of Marketing to its Leadership Team, Accelerating Its Growth and Expansion Plans
August 04, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
20 Stocks Moving in Friday's Pre-Market Session
July 30, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 50.9% to $6.20 in pre-market trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation...
Via
Benzinga
68 Biggest Movers From Yesterday
August 10, 2021
Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a...
Via
Benzinga
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2021
July 28, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.